Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 245

1.

The value of serum prostate specific antigen determinations before and after radical prostatectomy.

Lange PH, Ercole CJ, Lightner DJ, Fraley EE, Vessella R.

J Urol. 1989 Apr;141(4):873-9.

PMID:
2467013
[PubMed - indexed for MEDLINE]
2.

Prostate specific antigen in the diagnosis and treatment of adenocarcinoma of the prostate. II. Radical prostatectomy treated patients.

Stamey TA, Kabalin JN, McNeal JE, Johnstone IM, Freiha F, Redwine EA, Yang N.

J Urol. 1989 May;141(5):1076-83.

PMID:
2468795
[PubMed - indexed for MEDLINE]
3.

Prostate specific antigen in the preoperative and postoperative evaluation of localized prostatic cancer treated with radical prostatectomy.

Oesterling JE, Chan DW, Epstein JI, Kimball AW Jr, Bruzek DJ, Rock RC, Brendler CB, Walsh PC.

J Urol. 1988 Apr;139(4):766-72.

PMID:
2451037
[PubMed - indexed for MEDLINE]
4.

Clinical use of prostate specific antigen in patients with prostate cancer.

Hudson MA, Bahnson RR, Catalona WJ.

J Urol. 1989 Oct;142(4):1011-7.

PMID:
2477559
[PubMed - indexed for MEDLINE]
5.

Correlation of clinical and pathologic factors with rising prostate-specific antigen profiles after radical prostatectomy alone for clinically localized prostate cancer.

Kupelian P, Katcher J, Levin H, Zippe C, Klein E.

Urology. 1996 Aug;48(2):249-60.

PMID:
8753737
[PubMed - indexed for MEDLINE]
6.

Importance of tumor location in patients with high preoperative prostate specific antigen levels (greater than 20 ng/ml) treated with radical prostatectomy.

Magheli A, Rais-Bahrami S, Peck HJ, Walsh PC, Epstein JI, Trock BJ, Gonzalgo ML.

J Urol. 2007 Oct;178(4 Pt 1):1311-5. Epub 2007 Aug 16.

PMID:
17698095
[PubMed - indexed for MEDLINE]
7.

Prostatic specific antigen and prostatic acid phosphatase in the monitoring and staging of patients with prostatic cancer.

Ercole CJ, Lange PH, Mathisen M, Chiou RK, Reddy PK, Vessella RL.

J Urol. 1987 Nov;138(5):1181-4.

PMID:
2444720
[PubMed - indexed for MEDLINE]
8.

The relationship of prostate specific antigen levels and residual tumor volume in stage A prostate cancer.

Carter HB, Partin AW, Epstein JI, Chan DW, Walsh PC.

J Urol. 1990 Nov;144(5):1167-70; discussion 1170-1.

PMID:
1700143
[PubMed - indexed for MEDLINE]
9.

Preoperative PSA level significantly associated with interval to biochemical progression after radical retropubic prostatectomy.

Gonzalez CM, Roehl KA, Antenor JV, Blunt LW, Han M, Catalona WJ.

Urology. 2004 Oct;64(4):723-8.

PMID:
15491709
[PubMed - indexed for MEDLINE]
10.
11.

The effect of radiation therapy after radical prostatectomy in patients with elevated prostate specific antigen levels.

Lange PH, Lightner DJ, Medini E, Reddy PK, Vessella RL.

J Urol. 1990 Oct;144(4):927-32; discussion 932-3.

PMID:
1697918
[PubMed - indexed for MEDLINE]
12.

Prostate specific antigen kinetics at tumor recurrence after radical prostatectomy do not suggest a worse disease prognosis in black men.

Bissonette EA, Fulmer BR, Petroni GR, Moul JW, Theodorescu D.

J Urol. 2001 Oct;166(4):1328-31; discussion 1331-2.

PMID:
11547067
[PubMed - indexed for MEDLINE]
13.
14.

Prostate specific antigen in the diagnosis and treatment of adenocarcinoma of the prostate. III. Radiation treated patients.

Stamey TA, Kabalin JN, Ferrari M.

J Urol. 1989 May;141(5):1084-7.

PMID:
2468796
[PubMed - indexed for MEDLINE]
15.

The contemporary value of pretreatment prostatic acid phosphatase to predict pathological stage and recurrence in radical prostatectomy cases.

Moul JW, Connelly RR, Perahia B, McLeod DG.

J Urol. 1998 Mar;159(3):935-40.

PMID:
9474187
[PubMed - indexed for MEDLINE]
16.

Nuclear deoxyribonucleic acid ploidy and serum prostate specific antigen in operable prostatic adenocarcinoma.

Nativ O, Myers RP, Farrow GM, Therneau TM, Zincke H, Lieber MM.

J Urol. 1990 Aug;144(2 Pt 1):303-6.

PMID:
1695690
[PubMed - indexed for MEDLINE]
17.

Preoperative serum acid phosphatase and alkaline phosphatase are not predictors of pathological stage and prostate-specific antigen failure after radical prostatectomy.

San Francisco IF, Olumi AF, Yoon JH, Regan MM, DeWolf WC.

BJU Int. 2003 Dec;92(9):924-8.

PMID:
14632848
[PubMed - indexed for MEDLINE]
18.

Preoperative prostate-specific antigen in predicting pathologic stage and grade after radical prostatectomy.

Winter HI, Bretton PR, Herr HW.

Urology. 1991 Sep;38(3):202-5.

PMID:
1716021
[PubMed - indexed for MEDLINE]
19.

Prostate specific antigen and local recurrence after radical prostatectomy.

Lightner DJ, Lange PH, Reddy PK, Moore L.

J Urol. 1990 Oct;144(4):921-6.

PMID:
1697917
[PubMed - indexed for MEDLINE]
20.

Prostate specific antigen in the diagnosis and treatment of adenocarcinoma of the prostate. I. Untreated patients.

Stamey TA, Kabalin JN.

J Urol. 1989 May;141(5):1070-5.

PMID:
2468794
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk